Literature DB >> 16862246

Psychopharmacology for the clinician. Treating depression with selective norepinephrine reuptake inhibitors.

Pierre Blier1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16862246      PMCID： PMC1488907     

Source DB:  PubMed          Journal:  J Psychiatry Neurosci        ISSN： 1180-4882            Impact factor:   6.186


× No keyword cloud information.
  4 in total

Review 1.  Chronic MPTP administration regimen in monkeys: a model of dopaminergic and non-dopaminergic cell loss in Parkinson's disease.

Authors:  Gunasingh J Masilamoni; Yoland Smith
Journal:  J Neural Transm (Vienna)       Date:  2017-08-31       Impact factor: 3.575

2.  Cortical serotonin and norepinephrine denervation in parkinsonism: preferential loss of the beaded serotonin innervation.

Authors:  Tultul Nayyar; Michael Bubser; Marcus C Ferguson; M Diana Neely; J Shawn Goodwin; Thomas J Montine; Ariel Y Deutch; Twum A Ansah
Journal:  Eur J Neurosci       Date:  2009-07       Impact factor: 3.386

Review 3.  Off-label use of atomoxetine in adults: is it safe?

Authors:  Rana Dadashova; Peter H Silverstone
Journal:  Ment Illn       Date:  2012-09-24

Review 4.  A review of the efficacy of atomoxetine in the treatment of attention-deficit hyperactivity disorder in children and adult patients with common comorbidities.

Authors:  David B Clemow; Chris Bushe; Michele Mancini; Michael H Ossipov; Himanshu Upadhyaya
Journal:  Neuropsychiatr Dis Treat       Date:  2017-02-03       Impact factor: 2.570
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.